Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 5, 2013, Pages

  Rabenhorst, Anja ^a   Christopeit, Bastian ^a   Leja, Silke ^a   Gerbaulet, Alexander ^b   Kleiner, Svea ^c   Förster, Anja ^a   Raap, Ulrike ^c   Wickenhauser, Claudia ^d   Hartmann, Karin ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYTOKINE; DICKKOPF 1 PROTEIN; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; SCLEROSTIN; STEM CELL FACTOR; TRYPTASE; VITAMIN D;

BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMUR NECK; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LETTER; LUMBAR SPINE; MAST CELL; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SYSTEMIC MASTOCYTOSIS;

EID: 84887018065     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.06.019     Document Type: Article

References (9)

1. H.P. Horny, D.D. Metcalfe, J.M. Bennett, B.J. Bain, C. Akin, and L. Escribano Mastocytosis E.S. Jaffe, N.L. Harris, H. Stein, V. JW, World Health Organization classification of tumours pathology and genetics of tumours of the haematopoietic and lymphoid tissues 2008 IARC Press Lyon 54 63
2. L. Escribano, I. Alvarez-Twose, L. Sánchez-Muñoz, A. Garcia-Montero, R. Núñez, and J. Almeida Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients J Allergy Clin Immunol 124 2009 514 521
3. K Hartmann, N Wagner, A Rabenhorst, L Pflanz, S Leja, and A Förster Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients J Allergy Clin Immunol 132 2013 232 235.e4
4. N. Guillaume, J. Desoutter, O. Chandesris, L. Merlusca, I. Henry, and S. Georgin-Lavialle Bone complications of mastocytosis: a link between clinical and biological characteristics Am J Med 126 2013 75.e1 75.e7
5. E. van der Veer, W. van der Goot, J.G. de Monchy, H.C. Kluin-Nelemans, and J.J. van Doormaal High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis Allergy 67 2012 431 438
6. M. Rossini, R. Zanotti, P. Bonadonna, A. Artuso, B. Caruso, and D. Schena Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis Bone 49 2011 880 885
7. S. Barete, N. Assous, C. de Gennes, C. Grandpeix, F. Feger, and F. Palmerini Systemic mastocytosis and bone involvement in a cohort of 75 patients Ann Rheum Dis 69 2010 1838 1841
8. N.M. Kushnir-Sukhov, E. Brittain, J.C. Reynolds, C. Akin, and D.D. Metcalfe Elevated tryptase levels are associated with greater bone density in a cohort of patients with mastocytosis Int Arch Allergy Immunol 139 2006 265 270
9. H. Takayanagi New developments in osteoimmunology Nat Rev Rheumatol 8 2012 684 689